AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system
AivoCode has raised $600K in total funding. The most recent round was Grant. The last funding was announced in March 2024.
AivoCode's investors include National Science Foundation, National Institutes of Health.
AivoCode is headquartered in San Diego, United States.
AivoCode is an emerging biotech focused on critical and highly prevalent diseases affecting the central nervous system
AivoCode is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AivoCode — Funding & Investors." VCBacked, March 28, 2024, https://www.vcbacked.co/company/aivocode. Accessed September 16, 2026.
VCBacked. (2024). AivoCode — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/aivocode
{{cite web |title=AivoCode — Funding & Investors |url=https://www.vcbacked.co/company/aivocode |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated